Natera, Inc. Announces Launch of Vistara Single-Gene Mutation NIPT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Natera (NTRA) PT Raised to $16 at Canaccord Genuity Following 1Q
May 10, 2017 8:45 AM EDTCanaccord Genuity raised its price target on Natera (NASDAQ: NTRA) to $16.00 (from $14.00) while maintaining a Buy rating. NTRA reported 1Q revenues of $46.9M beating the Street's $42.8 estimate.
NTRA reiterated 2017 revenue guidance of $210-230M, compared to the Street's $218.6M. Analyst Mark... More
